The Free Radical Theory is a popular theory in neurology, which in general terms proposes that oxidative stress is a major factor leading to damage in neurological diseases. The theory has been proposed in order to explain the observed decline in neurological function that occurs in brain injury, aging, and neurological diseases. According to the theory, free radicals are molecules that are highly reactive because they contain unpaired electrons. Free radicals cause damage to cells and tissues by reacting with proteins, lipids, and DNA, leading to oxidative stress. This oxidative stress leads to the production of inflammatory mediators and to the generation of reactive oxygen species, which may damage neurons and other cells, leading to proteins and lipid damage. In neurological diseases, such as Alzheimer's and Parkinson's disease, there is evidence that free radicals play an important role in the pathology. It has been found that both diseases are associated with an increased level of oxidative stress, which is likely due to the accumulation of free radicals. In addition, studies suggest that the presence of antioxidants can reduce the oxidative damage caused by free radicals, offering some protective advantages. Other studies have focused on the role of iron and other metals in the production of free radicals, with findings suggesting that their presence can also contribute to the oxidative burden in neurological diseases. The Free Radical Theory can also explain the role of aging in neurological decline. As we age, the level of free radicals in our brain increases, leading to an accumulation of oxidative stress. This can result in the damage of nerve cells and other components of the brain, leading to degenerative changes that are associated with aging. Furthermore, it has been proposed that this oxidative damage may be the underlying cause of both Parkinson's and Alzheimer's disease. In general, the Free Radical Theory provides a strong scientific basis for understanding the pathological mechanisms of neurological diseases. It provides a convincing explanation for the observed decline in neurological function in brain injury, aging, and neurological diseases, and it offers potential therapeutic targets for the treatment of these conditions. Thus, understanding the role of free radicals in neurological diseases is an important step in the development of innovative treatments for these debilitating conditions.
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : TBI updates in 2025
Jonathan Eskenazi, Cedars Sinai / UCLA, United States
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Non-pharmacological strategies to counteract oxaliplatin toxicity: Protective effects of vagal nerve stimulation and resistance training on neuropathy, motor dysfunction, and muscle atrophy
Ricardo Aparecido Baptista Nucci, Hospital Sirio-Libanes, Brazil
Title : Synapticare: Integrating sleep data and tau biomarkers to assess depression severity
Medha Menon, John Foster Dulles HS, United States
Title : How have we eliminated infection: From the bone to brain?
Thomas J Webster, Interstellar Therapeutics, United States